ID   HPC-YS
AC   CVCL_6921
DR   Wikidata; Q54890267
RX   DOI=10.4172/2324-9293.1000104;
RX   PubMed=2208167;
CC   Population: Japanese.
CC   Doubling time: 31 hours (PubMed=2208167).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
RX   DOI=10.4172/2324-9293.1000104;
RA   Wagenhauser M.U., Ruckert F., Niedergethmann M., Grutzmann R.,
RA   Saeger H.-D.;
RT   "Distribution of characteristic mutations in native ductal
RT   adenocarcinoma of the pancreas and pancreatic cancer cell lines.";
RL   Cell Biol. Res. Ther. 2:1000104.1-1000104.5(2013).
//
RX   PubMed=2208167;
RA   Yamaguchi N., Yamamura Y., Koyama K., Ohtsuji E., Imanishi J.,
RA   Ashihara T.;
RT   "Characterization of new human pancreatic cancer cell lines which
RT   propagate in a protein-free chemically defined medium.";
RL   Cancer Res. 50:7008-7014(1990).
//